The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

MONDAY, Jan. 27, 2025 (HealthDay News) -- Reports of cats becoming seriously ill or dying after consuming raw pet food or ...

In 2022, Congress passed the FDAMA 2.0, which Kennedy helped introduce and Pres. Joe Biden signed into law. The law removes a requirement under the Federal Food, Drug and Cosmetic Act for mandatory ...

President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...

On January 15, 2025, the Food and Drug Administration (FDA) amended its color additive regulations by revoking its ...

The Association of Com­munity Pharmacists of Nigeria (ACPN) has called for amendments to some sections of the Fake Drug and Unwholesome Foods Act to enhance the effectiveness of the legislation in ...

Yet again, the premium cigar industry has prevailed in federal court against the U.S. Food and Drug Administration (FDA). FDA ...

(Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner ...

Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...

President Donald Trump signed the bipartisan Laken Riley Act into law as his administration’s first piece of legislation.

A bold new bill to allow AI chatbots to prescribe controlled drugs has been introduced into the House for review.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...